These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 16188399

  • 1. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C, Prado R.
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [Abstract] [Full Text] [Related]

  • 2. Methodology for reorganization of the cervical cancer program in Chile.
    Salas I.
    Cancer Detect Prev; 2006; 30(1):38-43. PubMed ID: 16504420
    [Abstract] [Full Text] [Related]

  • 3. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R, Budukh AM, Rajkumar R.
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [Abstract] [Full Text] [Related]

  • 4. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ, Chirenje ZM.
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [Abstract] [Full Text] [Related]

  • 5. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
    Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M.
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 7. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M, Daltveit AK, Thoresen SO, Nygård JF.
    BMC Health Serv Res; 2007 Jan 23; 7():10. PubMed ID: 17244348
    [Abstract] [Full Text] [Related]

  • 8. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF, Werner B, Totsugui J, Collaço LM, Araújo SR, Huçulak M, Boza EJ, Fischer RM, De Laat L, Sobbania LC, Raggio A.
    Diagn Cytopathol; 2003 Jul 23; 29(1):49-54. PubMed ID: 12827718
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ, Leung GM, Woo PP, Goldie SJ.
    J Public Health (Oxf); 2004 Jun 23; 26(2):130-7. PubMed ID: 15284314
    [Abstract] [Full Text] [Related]

  • 10. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B, Grinsted P.
    Ugeskr Laeger; 2006 May 29; 168(22):2163-6. PubMed ID: 16768956
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL, Yen AM, Chen TH.
    J Med Screen; 2006 May 29; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [Abstract] [Full Text] [Related]

  • 12. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK, Nongkynrih B.
    Indian J Public Health; 2007 May 29; 51(4):216-21. PubMed ID: 18232160
    [Abstract] [Full Text] [Related]

  • 13. Why women still die from cervical cancer.
    Masood S.
    J Fla Med Assoc; 1997 May 29; 84(6):379-83. PubMed ID: 9379163
    [Abstract] [Full Text] [Related]

  • 14. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M, Audy-Jurković S, Kardum-Skelin I, Mahovlić V, Mozetic-Vrdoljak D, Ovanin-Rakić A.
    Coll Antropol; 2007 Apr 29; 31 Suppl 2():47-54. PubMed ID: 17598505
    [Abstract] [Full Text] [Related]

  • 15. Cervical cancer screening in Thailand: an overview.
    Sriamporn S, Khuhaprema T, Parkin M.
    J Med Screen; 2006 Apr 29; 13 Suppl 1():S39-43. PubMed ID: 17227641
    [Abstract] [Full Text] [Related]

  • 16. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 17. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG, Chew L, Wang SC.
    J Med Screen; 2006 May 07; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [Abstract] [Full Text] [Related]

  • 18. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
    Arrossi S, Ramos S, Paolino M, Sankaranarayanan R.
    Reprod Health Matters; 2008 Nov 07; 16(32):50-8. PubMed ID: 19027622
    [Abstract] [Full Text] [Related]

  • 19. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP, Saraiya M, McLean TA, Hannan J, Liesmann JM, Rose SW, Lawson HW.
    J Womens Health (Larchmt); 2005 Oct 07; 14(8):670-8. PubMed ID: 16232098
    [Abstract] [Full Text] [Related]

  • 20. Screening for cervical cancer: will women accept less?
    Sirovich BE, Woloshin S, Schwartz LM.
    Am J Med; 2005 Feb 07; 118(2):151-8. PubMed ID: 15694900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.